Efficacy and Safety of Viusid and Asbrip in Hospitalized Patients with Mild and Moderate COVID-19: A Randomized Controlled Trial

ISSN Print: 2164-2648
ISSN Online: 2164-2656
www.scirp.net/journal/aid
E-mail: [email protected]

Citations

"Efficacy and Safety of Viusid and Asbrip in Hospitalized Patients with Mild and Moderate COVID-19: A Randomized Controlled Trial"
written by Petar Petrov, Aleksandar Mihaylov, Maria Shopova, Maria Boncheva, David Marquez,
published by Advances in Infectious Diseases, Vol.11 No.2, 2021

has been cited by the following article(s):

[1]	Glycyrrhizin and boswellic acids, the golden nutraceuticals: multitargeting for treatment of mild–moderate COVID-19 and prevention of post-COVID cognitive …
	Wadood, MA Gomaa - Inflammopharmacology, 2022

[2]	Ocoxin oral solution demonstrates antiviral properties in cellular models
	2021

[1]	Effect and Safety of Viusid^® on Quality of Life in Patients with Chronic Kidney Disease Undergoing Haemodialysis Open Journal of Nephrology, 2025 DOI:10.4236/ojneph.2025.154048

[2]	Glycyrrhizin and boswellic acids, the golden nutraceuticals: multitargeting for treatment of mild–moderate COVID-19 and prevention of post-COVID cognitive impairment Inflammopharmacology, 2022 DOI:10.1007/s10787-022-01062-3

[3]	Ocoxin oral solution demonstrates antiviral properties in cellular models Experimental and Therapeutic Medicine, 2021 DOI:10.3892/etm.2021.10561